JANELLE ROMERO: Open Payments
NPI 1689901860 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 24 payments from 10 companies in 2025. Trend: 2023 $1,349 · 2024 $1,825 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $322 |
| Boston Scientific Corporation | 1 | $172 |
| ABBVIE INC. | 3 | $153 |
| Amgen Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: WATCHMAN FLX, Wegovy, VRAYLAR, Ozempic, OTEZLA, Veozah, PREVNAR 20, Rybelsus.
Industry payments across AZ — which companies pay providers there.
